Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Knobbe Martens Client iRhythm Technologies, Inc. Announced Pricing of Initial Public Offering

October 25, 2016  | Gerard von Hoffmann, David Schmidt, Ph.D., Irfan Lateef and Harnik Shukla

Read the full press release here

Knobbe Martens Client iRhythm Technologies, Inc. Announced Pricing of Initial Public Offering Headshot

Gerard von Hoffmann
Partner
San Diego
gerard.vonhoffmann@knobbe.com
858-707-4000
Knobbe Martens Client iRhythm Technologies, Inc. Announced Pricing of Initial Public Offering Headshot

David Schmidt, Ph.D.
Partner
Orange County
david.schmidt@knobbe.com
949-760-0404
Knobbe Martens Client iRhythm Technologies, Inc. Announced Pricing of Initial Public Offering Headshot

Irfan Lateef
Partner
Orange County
irfan.lateef@knobbe.com
949-760-0404
Knobbe Martens Client iRhythm Technologies, Inc. Announced Pricing of Initial Public Offering Headshot

Harnik Shukla
Partner
Orange County
harnik.shukla@knobbe.com
949-760-0404

Related Links

Practice Areas

Industries

News & Insights

News
Nov 2025
Knobbe Martens Advises Pacira BioSciences in Exclusive License Agreement with AmacaThera for Novel Long-Acting Analgesic
Agreement will support the development and commercialization of non-opioid therapy for postsurgical pain control IRVINE, Calif., November 4, 2025 – A team from Knobbe Martens advised Pacira BioSciences, Inc. in...
News
Oct 2025
Knobbe Martens Secures Federal Circuit Win for Edwards Lifesciences in Prosthetic Heart Valve Patent Dispute
IRVINE, Calif., October 29, 2025 –  Knobbe Martens is pleased to announce the firm has obtained a significant appellate victory for Edwards Lifesciences in a high-stakes patent infringement dispute involving...
News
Oct 2025
Knobbe Martens Secures TTAB Victory for BW Essentials LLC in Trademark Opposition Over “TROOMY” Brand
IRVINE, Calif., October 22, 2025 – A team from Knobbe Martens successfully represented BW Essentials LLC, maker of Troomy Nootropics supplements, in a contested trademark opposition before the U.S. Patent...